Active Ingredient(s): Hexaminolevulinate Hydrochloride
FDA Approved: * May 28, 2010
Pharm Company: * PHOTOCURE ASA
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cysview Overview

Hexyl aminolevulinate hydrochloride, sold under the brand names Cysview and Hexvix, is an imaging agent that lights up under blue light during a blue light cystoscopy. It is used to help detect non-muscle invasive bladder cancer (NMIBC), in particular papillary tumors and carcinoma in situ (CIS). In 2016, the American Urological Association (AUA) made the following statement with respect to NMIBC:[1] "In a patient with a history of NMIBC with normal cystoscopy and positive c...

Read more Cysview Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Cysview Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Hexaminolevulinate Hydrochloride
  • For Solution: 100mg/vial
  • Solution: 100mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cysview: (2 results)

Sorted by National Drug Code

Other drugs which contain Hexaminolevulinate Hydrochloride or a similar ingredient: (1 result)